RNA
$71.86
Revenue | $12.48Mn |
Net Profits | $-174.44Mn |
Net Profit Margins | -1398.33% |
Avidity Biosciences Inc’s revenue jumped 434.03% since last year same period to $12.48Mn in the Q3 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated 224.28% jump in its revenue since last 3-months.
Avidity Biosciences Inc’s net profit fell -116.97% since last year same period to $-174.44Mn in the Q3 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated -10.89% fall in its net profits since last 3-months.
Avidity Biosciences Inc’s net profit margin jumped 59.37% since last year same period to -1398.33% in the Q3 2025. On a quarterly growth basis, Avidity Biosciences Inc has generated 65.81% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.14 |
EPS Estimate Current Year | -1.14 |
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -1.14 - a -19.22% fall from last quarter’s estimates.
Avidity Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -1.14.
Earning Per Share (EPS) | 0 |
Avidity Biosciences Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Avidity Biosciences Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-07 | -0.96 | -1.21 | -26.54% |
2025-05-08 | -0.88 | -0.9 | -2.24% |
2025-11-10 | -1.14 | 0 | 100% |